secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2022-06-28T23:59:59+00:00
Accession:  0001104659-22-075039
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie appoints Robert Michael as Vice Chairman and President; Scott Reents as CFO
--------------------------------------------------------------------------------

- Robert A. Michael, previously CFO, named Vice Chairman and President effective June 23, 2022.
- Scott T. Reents, formerly VP Tax and Treasury, appointed Senior Vice President and CFO effective June 23, 2022.
- Both appointments are internal promotions; Michael joined Abbott in 1993, Reents in 2008.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/0001104659-22-075039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/tm2219549d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-075039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer